Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Controlled Trial of Sertraline in Young Children With Fragile X Syndrome
Brief Summary: This study is a control trial of sertraline (Zoloft) in fragile X syndrome children aged 2 years to 5 years 8 months old. The trial is six months long, and each participant will receive a series of tests at both the beginning and end of the study. The researchers hope to show improvements in language and a decrease in autistic symptoms.